67 related articles for article (PubMed ID: 25325557)
21. Tuning reactivity of diphenylpropynone derivatives with metal-associated amyloid-β species via structural modifications.
Liu Y; Kochi A; Pithadia AS; Lee S; Nam Y; Beck MW; He X; Lee D; Lim MH
Inorg Chem; 2013 Jul; 52(14):8121-30. PubMed ID: 23805940
[TBL] [Abstract][Full Text] [Related]
22. Multiple ligand binding sites on A beta(1-40) fibrils.
LeVine H
Amyloid; 2005 Mar; 12(1):5-14. PubMed ID: 16076606
[TBL] [Abstract][Full Text] [Related]
23. Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.
Scherzer-Attali R; Farfara D; Cooper I; Levin A; Ben-Romano T; Trudler D; Vientrov M; Shaltiel-Karyo R; Shalev DE; Segev-Amzaleg N; Gazit E; Segal D; Frenkel D
Neurobiol Dis; 2012 Jun; 46(3):663-72. PubMed ID: 22449754
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic redistribution of metal ions to treat Alzheimer's disease.
Crouch PJ; Barnham KJ
Acc Chem Res; 2012 Sep; 45(9):1604-11. PubMed ID: 22747493
[TBL] [Abstract][Full Text] [Related]
25. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
Fodero-Tavoletti MT; Mulligan RS; Okamura N; Furumoto S; Rowe CC; Kudo Y; Masters CL; Cappai R; Yanai K; Villemagne VL
Eur J Pharmacol; 2009 Sep; 617(1-3):54-8. PubMed ID: 19576880
[TBL] [Abstract][Full Text] [Related]
26. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
[TBL] [Abstract][Full Text] [Related]
27. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease.
Wang L; Sato H; Zhao S; Tooyama I
Neurosci Lett; 2010 Sep; 481(3):164-7. PubMed ID: 20599473
[TBL] [Abstract][Full Text] [Related]
28. Liberation of copper from amyloid plaques: making a risk factor useful for Alzheimer's disease treatment.
Geng J; Li M; Wu L; Ren J; Qu X
J Med Chem; 2012 Nov; 55(21):9146-55. PubMed ID: 22663067
[TBL] [Abstract][Full Text] [Related]
29. Diphenylpropynone derivatives as probes for imaging β-amyloid plaques in Alzheimer's brains.
Ono M; Watanabe H; Watanabe R; Haratake M; Nakayama M; Saji H
Bioorg Med Chem Lett; 2011 Jan; 21(1):117-20. PubMed ID: 21145738
[TBL] [Abstract][Full Text] [Related]
30. Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease.
Opazo C; Luza S; Villemagne VL; Volitakis I; Rowe C; Barnham KJ; Strozyk D; Masters CL; Cherny RA; Bush AI
Aging Cell; 2006 Feb; 5(1):69-79. PubMed ID: 16441845
[TBL] [Abstract][Full Text] [Related]
31. Insight into amyloid structure using chemical probes.
Reinke AA; Gestwicki JE
Chem Biol Drug Des; 2011 Jun; 77(6):399-411. PubMed ID: 21457473
[TBL] [Abstract][Full Text] [Related]
32. PicoGreen: a better amyloid probe than Thioflavin-T.
Mora AK; Singh PK; Patro BS; Nath S
Chem Commun (Camb); 2016 Oct; 52(82):12163-12166. PubMed ID: 27709200
[TBL] [Abstract][Full Text] [Related]
33. Activatable Small-Molecule Photoacoustic Probes that Cross the Blood-Brain Barrier for Visualization of Copper(II) in Mice with Alzheimer's Disease.
Wang S; Sheng Z; Yang Z; Hu D; Long X; Feng G; Liu Y; Yuan Z; Zhang J; Zheng H; Zhang X
Angew Chem Int Ed Engl; 2019 Sep; 58(36):12415-12419. PubMed ID: 31309679
[TBL] [Abstract][Full Text] [Related]
34. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.
Zhang Z; Song M; Liu X; Kang SS; Kwon IS; Duong DM; Seyfried NT; Hu WT; Liu Z; Wang JZ; Cheng L; Sun YE; Yu SP; Levey AI; Ye K
Nat Med; 2014 Nov; 20(11):1254-62. PubMed ID: 25326800
[TBL] [Abstract][Full Text] [Related]
35. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.
Tu S; Okamoto S; Lipton SA; Xu H
Mol Neurodegener; 2014 Nov; 9():48. PubMed ID: 25394486
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of amyloid-β fibril elongation.
Gurry T; Stultz CM
Biochemistry; 2014 Nov; 53(44):6981-91. PubMed ID: 25330398
[TBL] [Abstract][Full Text] [Related]
37. β-Amyloid peptides and amyloid plaques in Alzheimer's disease.
Gouras GK; Olsson TT; Hansson O
Neurotherapeutics; 2015 Jan; 12(1):3-11. PubMed ID: 25371168
[TBL] [Abstract][Full Text] [Related]
38. ATF4: a Novel Potential Therapeutic Target for Alzheimer's Disease.
Wei N; Zhu LQ; Liu D
Mol Neurobiol; 2015 Dec; 52(3):1765-1770. PubMed ID: 25381575
[TBL] [Abstract][Full Text] [Related]
39. Preparation protocols of aβ(1-40) promote the formation of polymorphic aggregates and altered interactions with lipid bilayers.
Yates EA; Legleiter J
Biochemistry; 2014 Nov; 53(45):7038-50. PubMed ID: 25349919
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
